MAKO Surgical Corp. (NASDAQ: MAKO) increased 8.52% to $31.23 in the morning hour after the company reported fourth quarter 2011 and full year highlights. MAKO also anticipates that it will sell 56 to 62 RIO systems and that its customers will perform 11,000 to 13,000 MAKOplasty procedures in 2012.
Acorda Therapeutics Inc. (NASDAQ: ACOR) climbed 3% to $26.45 in the early hour after the company announced that AMPYRA(R) Extended Release Tablets, 10 mg unaudited net sales for the fourth quarter of 2011 were $57 million and unaudited AMPYRA 2011 full year net sales were $210 million. These results are subject to completion of the Company’s year-end audit.
OpenTable Inc (NASDAQ:OPEN) increased % to $ in the early hour. The 52 week trading range for the company is $31.54 – $118.66. The company has declined over 47% in the last one year. OpenTable provides solution that forms an online network connecting reservation-taking restaurants and people who dine at those restaurants. Its solutions include its electronic reservation book (ERB) and and OpenTable Connect (Connect).
Jones Apparel Group, Inc. (NYSE: JNY) plunged 3.33% to $9.0 in the early hour after the company announced that it has terminated all discussions regarding the potential sale of Jones’ Jeanswear division and that it intends to maintain ownership and normal operations of the division.
Perfect World Co., Ltd. (ADR) (NASDAQ: PWRD) plunged 23.08% to $9.23 in the early hour. The 52 week trading range for the company is $8.81 – $9.10. Perfect World is an online game developer and operator in People’s Republic of China. Perfect World develops online games based on its game engines and game development platforms.
The assembled information distributed by headlineotc.com is for information purposes only, and is neither a solicitation to buy nor an offer to sell securities. Headlineotc.com does expect that investors will buy and sell securities based on information assembled and presented herein. Headlineotc.com will not be responsible in any way for or accept any liability for any losses arising from an investor’s reliance on or use of information obtained from our website or emails. PLEASE always do your own due diligence, and consult your financial adviser.